Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Peripheral Nervous System Diseases 5Lymphoma 5Head and Neck Neoplasms 4Breast Neoplasms 4Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Colorectal Neoplasms 3Stomatitis 2Stomach Neoplasms 2Sarcoma 2Pain 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Multiple Myeloma 2Mucositis 2Malnutrition 2Wilms Tumor 1Vaso-Occlusive Crises 1Squamous Cell Carcinoma of Head and Neck 1Sarcopenia 1Recurrence 1Radiation Injuries 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Oral Complications 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Multiple Endocrine Neoplasia Type 1 1Malignant mesenchymal tumor 1

Interventions

avasopasem manganese 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiation 1Induction Chemotherapy 1Immunonutrition Diet 1Heart Rate 1Glutamine 1Gastropexy 1Fundoplication 1Esomeprazole 1Endoscopy, Digestive System 1Drug Therapy 1Dietary Supplements 1Biopsy 1Amifostine 1Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagitis × Glutamine × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡